Back

Engineering a PD-L1-sensing synthetic receptor for programmable macrophage-mediated phagocytosis

De Martino, I.; Russo, L.; Marchetti, M.; Siciliano, V.

2026-01-21 synthetic biology
10.64898/2026.01.21.700810 bioRxiv
Show abstract

Macrophages are abundant immune cells within the tumor microenvironment with intrinsic phagocytic capabilities, yet their antitumor functions are frequently suppressed by inhibitory signals. Synthetic biology enables the rational design of ligand-responsive genetic circuits to reprogram immune cell behavior. Here, we report the engineering of a synthetic Notch-based receptor that detects PD-L1, an immune-checkpoint broadly expressed by cancer cells. Upon PD-L1 engagement, the circuit triggers programmable outputs, including expression of a fluorescent reporter or CV1-Fc, that locally blocks the CD47 "dont eat me" signal. We show that circuit activation scales with PD-L1 levels, partially attenuates PD-1/PD-L1 signaling, and that conditional CV1-Fc expression enhances engulfment of SKOV-3 ovarian cancer cells by THP-1-derived macrophages in vitro. Collectively, this work reframes PD-L1 from an end-point therapeutic target to a primary input signal for synthetic circuit activation and establishes a modular framework for engineering macrophage behaviour through spatially confined, ligand-responsive control. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/700810v1_ufig1.gif" ALT="Figure 1"> View larger version (60K): org.highwire.dtl.DTLVardef@1cbb391org.highwire.dtl.DTLVardef@7a0900org.highwire.dtl.DTLVardef@1e4f6d6org.highwire.dtl.DTLVardef@109838d_HPS_FORMAT_FIGEXP M_FIG Graphical abstract. A novel -PDL1 SNIPR receptor to program macrophage outputs. PD-L1 expressed on cancer cells is detected by -PD-L1 SNIPR-engineered macrophages, triggering release of the GAL4-VP64 transcription factor and activation of a programmable actuator. Circuit activation leads to customized outputs, including biosensing and enhanced macrophage phagocytosis via CD47 blockade, as well as immunomodulatory effects through interference with the PD-1/PD-L1 checkpoint axis. This sensor-actuator framework enables spatially confined and ligand-dependent reprogramming of macrophage function. C_FIG

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Nature Communications
5641 papers in training set
Top 15%
12.1%
2
Science Advances
1243 papers in training set
Top 0.9%
10.8%
3
eLife
5828 papers in training set
Top 15%
7.4%
4
Cell Death & Differentiation
48 papers in training set
Top 0.1%
5.6%
5
ACS Synthetic Biology
287 papers in training set
Top 0.7%
5.2%
6
Frontiers in Immunology
638 papers in training set
Top 3%
4.4%
7
Journal of Biological Engineering
12 papers in training set
Top 0.1%
3.3%
8
Advanced Science
286 papers in training set
Top 2%
3.3%
50% of probability mass above
9
EMBO Reports
263 papers in training set
Top 3%
2.2%
10
Nature Biomedical Engineering
47 papers in training set
Top 0.5%
2.2%
11
Journal for ImmunoTherapy of Cancer
75 papers in training set
Top 1.0%
1.9%
12
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 30%
1.5%
13
iScience
1154 papers in training set
Top 21%
1.5%
14
Journal of Biological Chemistry
690 papers in training set
Top 6%
1.4%
15
Cancer Letters
35 papers in training set
Top 0.7%
1.1%
16
Scientific Reports
3612 papers in training set
Top 64%
1.1%
17
Nature Chemical Biology
119 papers in training set
Top 2%
1.1%
18
Communications Biology
993 papers in training set
Top 20%
1.1%
19
Cancer Cell
42 papers in training set
Top 1.0%
1.1%
20
PLOS ONE
5266 papers in training set
Top 54%
1.1%
21
ACS Nano
113 papers in training set
Top 2%
1.1%
22
Molecular Therapy Oncology
10 papers in training set
Top 0.1%
1.1%
23
Molecular Therapy
81 papers in training set
Top 1%
1.1%
24
Cancer Immunology Research
35 papers in training set
Top 0.7%
1.0%
25
Advanced Healthcare Materials
85 papers in training set
Top 1%
1.0%
26
Journal of Translational Medicine
57 papers in training set
Top 2%
1.0%
27
Molecular Therapy - Nucleic Acids
25 papers in training set
Top 0.6%
0.9%
28
OncoImmunology
24 papers in training set
Top 0.6%
0.9%
29
Cell Reports
1498 papers in training set
Top 26%
0.9%
30
Science Translational Medicine
127 papers in training set
Top 3%
0.9%